Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.

China’s tobacco monopoly has become so financially vital to the government that even its powerful leader has failed to curb the country’s smoking habit.

The U.S. tech giant’s powerful H200 chip seemed poised to boost Beijing’s A.I. ambitions, but not a single one has been purchased in China.

A series of precedent-setting rulings signals that Chinese courts are being enlisted to shield workers from displacement by artificial intelligence.

The leaders of both countries are expected to discuss the risks from artificial intelligence, but neither country is willing to be the first to slow down.

Different strokes for different folks.

Beijing depended on Hungary’s outgoing leader, Viktor Orban, to gain a toehold in Europe. A giant battery factory proved a step too far.

A new level of global disorder will face the American and Chinese presidents at their summit. Like Mao and Nixon, they face a common threat.

Both parties can agree to do a whole lot on A.I., but they have to move faster.

Beijing’s insistence that Meta unwind its deal with a Chinese A.I. start-up escalates the geopolitical fight over advanced tech.

The Times unearthed memos that signaled a major shift in the court’s operations, in a decision that critics say was rushed and flawed.